GSK plc

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 10:05:19 12/03/2026 pm IST			5-day change	1st Jan Change
2,031.00 ^GBX	-1.69%		-2.17%	+11.32%

04:10pm	BioVersys AG Announces First Patient Dosed In Phase 2b Clinical Trial Of Alpe In Pulmonary Tuberculosis	CI
03:13pm	GSK : Barclays reiterates its Sell rating	ZD

Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.

Published on 02/10/2026 at 09:22 pm IST

S&P Capital IQ

GSK PLC

-1.69%

QUEST DIAGNOSTICS INCORPORATED

+0.91%

DOW JONES INDUSTRIAL

-1.12%

From October 1, 2025 to December 31, 2025, the company has repurchased 1,648,106 shares, representing 1.48% for $302.01 million. With this, the company has completed the repurchase of 96,743,670 shares, representing 69.11% for $9,070.72 million under the buyback announced on October 20, 2010.

Stocks mentioned in the article

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
GSK PLC	2,031.00GBX	-1.69%	-2.17%	11TCr
QUEST DIAGNOSTICS INCORPORATED	202.39USD	+0.91%	-0.89%	2.2TCr
DOW JONES INDUSTRIAL	46,886.16PTS	-1.12%	-2.21%	-

Latest news about GSK plc

04:10pm	BioVersys AG Announces First Patient Dosed In Phase 2b Clinical Trial Of Alpe In Pulmonary Tuberculosis	CI
03:13pm	GSK : Barclays reiterates its Sell rating	ZD
11:59am	UI Boustead REIT falls in market debut after Singapore's biggest IPO this year	RE
12/03	GSK plc Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 11:30 AM
11/03	FTSE 100 in the Red as US-Iran War Escalates; UK Commits to IEA Oil Stockpile Release	MT
11/03	AlphaValue/Baader Europe Upgrades GSK to Add, Lifts PT	MT
11/03	AlphaValue/Baader Europe Upbeat on GSK Earnings Growth; Rating, Price Target Revised	MT
11/03	The Market Is Looking Suspiciously Calm
11/03	GSK plc: Can bet on GSK’s gradually brightening future
11/03	GSK's Wellcovorin Becomes First US FDA-approved Therapy for Cerebral Folate Deficiency	MT
11/03	Oracle, the IEA, and off we go again?
10/03	US FDA Approves Expanded Use of GSK's Wellcovorin for Rare Neurological Condition	MT
10/03	Global markets live: Amazon, Meta, Goldman Sachs, OpenAI
10/03	GSK's Wellcovorin Tablets Approved by FDA for Expanded Use	MT
10/03	US FDA approves leucovorin for rare genetic disorder causing autism-like symptoms	RE

Chart GSK plc

Duration

Period

GSK: Dynamic Chart

Company Profile

GSK plc is a global biopharma company. The Companyâ€™s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.

Employees

66,841

Sector

Pharmaceuticals

More about the company